In the Fight for Hematology: Adetokunbo O’s Reflections from ASH25
Adetokunbo O, Medical Director – Oncology at AbbVie, shared on LinkedIn:
”I’m leaving the 67th ASH (American Society of Hematology) Annual Meeting and Exposition with a sense of responsibility and gratitude.
At a time when voices in some of the highest seats of power should be advocates for advancements in science and healthcare and the wellbeing of all, but are instead leading to confusion and reversing decades of progress through reckless legislation…..
I am grateful that in spite of the beating down and demoralization that scientists have felt these past couple of months…..
the work continues,
the fight continues,
the grit and courage remains palpable, relentless…and even more urgent and necessary.
For everyone who has lost a loved one to cancer and/or hematologic disease….hear us carefully…
We WILL NOT back down.
For my dear friend and colleague who lost his battle to complications of sickle cell disease, I have never forgotten you and we will continue to fight 4 hematology.
On days when we question if our work still matters, to my colleagues and fellow scientists – it ABSOLUTELY does.
Please stay in the fight.
We need each other to win.
I am so proud of my colleagues and teams, old and new, that continue the hard-work of making sure humans everywhere have access to evidence-based care, grounded in science and compassion.
Till we rendezvous again next year…..the work must go on.
Remain unstoppable and safe travels home!”

All from ASH25 featured in Hemostasis Today.
-
Mar 16, 2026, 19:16Maha Othman: Delighted to See Our Article Receive The Eberhard F. Mammen Most Popular Article Award 2026
-
Mar 16, 2026, 19:03Limited Evidence for Anticoagulation Despite High VTE Risk in Sickle Cell Disease – RPTH
-
Mar 16, 2026, 18:59Bartosz Hudzik: Choosing The Right Anticoagulant for Acute Venous Thromboembolism
-
Mar 16, 2026, 18:54Michael Recht Appointed Chief Medical and Scientific Advisor to NBDF’s Pathway to Cures
-
Mar 16, 2026, 18:46David McIntosh: Moving Beyond Doubts and Ensuring the Safety of Plasma Donation
-
Mar 16, 2026, 18:42Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke
-
Mar 16, 2026, 18:27Christina (Tina) P: Help Advance Research and Support Patients with Antiphospholipid Syndrome
-
Mar 16, 2026, 18:20Ahmed Koriesh: Stroke Prevention in the New 2026 ACC/AHA Dyslipidemia Guideline
-
Mar 16, 2026, 18:13Nameer Ascandar: Outcomes After GI Bleeding in Patients with Rheumatoid Arthritis and AF on Long-Term Oral Anticoagulation